ORMP
Companies
NASDAQ
Oramed Pharmaceuticals Inc.
Health Care
$2.15
-$0.30 (-12.60%)
Price Chart
Overview
About ORMP
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Market Cap
$85.3M
Volume
119.4K
Avg. Volume
138.6K
P/E Ratio
-26.875002
Dividend Yield
0.00%
Employees
17.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.66
Low Correlation
Volatility
High (0.58)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ORMP shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$85.3M
Volume119.4K
P/E Ratio-26.88
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
November 8, 2024Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025